SIBIONICS GS1

Regulatory Information:

The SIBIONICS GS1 Continuous Glucose Monitoring (CGM) system is a CE-marked medical device (CE Mark issued under EU MDR).

This app is only intended for use with SIBIONICS GS1 CGM sensors, which are legally available in the following countries and regions only:

Europe

Albania, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, North Macedonia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Ireland, Iceland, France, Finland, Greece, Hungary, Italy, Kosovo, Latvia, Lithuania, Luxembourg, Malta, Montenegro, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Sweden, Switzerland, Türkiye, Ukraine, United Kingdom

Asia

Afghanistan, Azerbaijan, Bahrain, Brunei, Hong Kong SAR, Indonesia, Iraq, Israel, Jordan, Kazakhstan, Kuwait, Macao SAR, Malaysia, Maldives, Mongolia, Oman, Pakistan, Qatar, Saudi Arabia, Singapore, South Korea, Sri Lanka, Tajikistan, Turkmenistan, United Arab Emirates, Uzbekistan, Vietnam

Africa

Algeria, Angola, Botswana, Côte d’Ivoire, Egypt, Ghana, Kenya, Libya, Madagascar, Mauritius, Morocco, Nigeria, Senegal, Seychelles, South Africa, Tunisia

North America & Caribbean

Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Panama, Trinidad and Tobago

South America

Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay, Venezuela

This app and device are NOT FDA-cleared and are not intended for sale or use in the United States or in any other country or region not listed above.

Disclaimer: Always consult your healthcare provider before making any treatment decisions. Do not use this app as a substitute for professional medical advice.